will filter after docket loads

Millennium Pharmaceuticals v. Sandoz Inc.

15-2066 | U.S. Court of Appeals, Federal Circuit

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Sept. 24, 2015
Terminated July 17, 2017
Judges PROST, NEWMAN, LOURIE, DYK, MOORE, O’MALLEY, REYNA, WALLACH, TARANTO, CHEN, HUGHES, STOLL, and MAYER
Nature of Suit 830 Patent
Original Case 1:12-cv-01011
Last Updated: 1 year, 9 months ago Show Interactive Timeline
Filing Date # Docket Text
10/27/2017Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [471000] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762]
10/20/2017152
  • Motion to Withdraw as CounselGranted
**TEXT ONLY** ORDER granting motion to withdraw attorney [151] Luke T. Shannon filed by Appellees Apotex Corp. and Apotex Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [469563]
10/20/2017
  • Motion to Withdraw as Counsel
MOTION of Appellee Apotex Corp. to withdraw counsel Luke T. Shannon. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/20/2017 by email. [469512]
10/19/2017
  • Order
ORDER filed denying [146] petition for panel rehearing filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hospira, Inc., Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd., Accord Healthcare, Inc., Glenmark Generics Ltd., Sun Pharma Global FZE, Actavis LLC, Sandoz Inc., Wockhardt USA LLC, Wockhardt Bio AG, Mylan Laboratories Limited, Agila Specialties Inc. and Sun Pharmaceutical Industries Limited; denying [146] petition for en banc rehearing filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hospira, Inc., Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd., Accord Healthcare, Inc., Glenmark Generics Ltd., Sun Pharma Global FZE, Actavis LLC, Sandoz Inc., Wockhardt USA LLC, Wockhardt Bio AG, Mylan Laboratories Limited, Agila Specialties Inc. and Sun Pharmaceutical Industries Limited. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [469158]
10/12/2017149
  • Motion to Withdraw as CounselGranted
**TEXT ONLY** ORDER granting motion to withdraw attorney [148] Anna E. Lumelsky filed by Appellant Millennium Pharmaceuticals, Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [467345]
10/12/2017
  • Motion to Withdraw as Counsel
MOTION of Appellant Millennium Pharmaceuticals, Inc. to withdraw counsel Anna E. Lumelsky. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/12/2017 by email. [467332]
9/18/201714718 paper copies of the petition for panel rehearing [146], petition for en banc rehearing [146] received from Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. [461731]
9/15/2017
  • Motion for Rehearing
Petition for panel rehearing, for en banc rehearing filed by Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG and Wockhardt USA LLC. Service: 09/15/2017 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 09/19/2017 [461545]
9/15/2017Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellee Sandoz Inc.. Service: 09/15/2017 by email. [461428]
9/15/2017Corrected Entry of appearance for Steffen N. Johnson as principal counsel for Appellee Sandoz Inc.. Service: 09/15/2017 by email. [461416]
9/15/2017Corrected Entry of appearance for George C. Lombardi as of counsel for Appellee Sandoz Inc.. Service: 09/15/2017 by email. [461408]
8/15/2017ORDER filed granting motion to extend time to file petition for rehearing [139] filed by Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hospira, Inc., Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd., Accord Healthcare, Inc., Glenmark Generics Ltd., Sun Pharma Global FZE, Actavis LLC, Sandoz Inc., Wockhardt USA LLC, Wockhardt Bio AG, Mylan Laboratories Limited, Agila Specialties Inc. and Sun Pharmaceutical Industries Limited Petition for Rehearing due on or before 09/15/2017. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [454004]
8/9/2017Corrected Entry of appearance for Andrew C. Nichols as of counsel for Appellee Sandoz Inc.. Service: 08/09/2017 by email. [452683]
8/9/2017140NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [138] filed by Appellee Sandoz Inc. in 15-2066 is indicating more than one principal attorney for the party(s) and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency [either Mr. Lombardi or Mr. Nichols must amend their appearance to reflect 'of counsel', or withdraw]. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [452660]
8/9/2017
  • Motion
MOTION of Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG and Wockhardt USA LLC to extend the time to file a Petiton or Panel Rehearing until 09/15/2017. [Consent: unopposed]. Service: 08/09/2017 by email. [452647]--[Edited 08/09/2017 by JP to remove incorrect filer party - Teva Pharmaceuticals USA, Inc.]
8/9/2017Entry of appearance for Andrew C. Nichols as principal counsel for Appellee Sandoz Inc.. Service: 08/09/2017 by email. [452643]
8/9/2017Entry of appearance for Steffen N. Johnson as of counsel for Appellee Sandoz Inc.. Service: 08/09/2017 by email. [452641]
7/17/2017
  • Motion for Judgment
OPINION and JUDGMENT filed. The judgment or decision is: Reversed-in-part and Remanded-in-part in 15-2066, 16-1008, 16-1009, 16-1010, 16-1110, 16-1283, 16-1762; Vacated-in-part and Remanded-in-part in 16-1109. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Mayer,Circuit Judge and O'Malley,Circuit Judge). [446874] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762]
2/6/2017135Submitted after ORAL ARGUMENT by
William F. Lee for Millennium Pharmaceuticals, Inc. and Thomas J. Meloro for Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC.
Panel: Judge: Newman , Judge: Mayer , Judge: O'Malley. [404790]
1/17/2017134
  • Response
Response to oral argument order from the Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. designating Thomas J. Meloro as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399691]
1/17/2017133
  • Response
Response to oral argument order from the Appellant Millennium Pharmaceuticals, Inc.. designating William F. Lee as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399278]
12/15/2016132NOTICE OF CALENDARING. Panel: 1702B. Case scheduled Feb 06, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 01/17/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [391314] THIS NOTICE APPLIES TO CASE(S): [15-2066, 16-1179, 16-1591, 16-1788]
11/9/2016Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (December 5, 2016 , January 9-13, February 13, and March 13, 2017). Service: 11/09/2016 by email. [381667]
11/2/2016Notice from Appellees Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (December 5-9, 2016; January 9-13, 2017). Service: 11/02/2016 by email. [379816]
10/14/2016Amended Certificate of Interest for the Appellee Actavis LLC. Service: 10/14/2016 by email. [374540]
9/28/2016Notice from Appellee Hospira, Inc. regarding conflicts with oral argument (December 5-9, 2016 and March 10, 2017). Service: 09/28/2016 by email. [369929]
9/27/2016Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (December 5, 2016 and January 9-13, 2017). Service: 09/27/2016 by email. [369548]
7/26/2016Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (August 1-5, November 4 and 7, and December 5, 2016). Service: 07/26/2016 by email. [353687]
7/18/2016Notice from Appellees Agila Specialties Inc. and Mylan Laboratories Limited regarding conflicts with oral argument (September 9, 2016). Service: 07/18/2016 by email. [351765]
7/18/2016Notice from Appellee Accord Healthcare Inc. regarding conflicts with oral argument (October 3-7, 2016; December 5-9, 2016). Service: 07/18/2016 by email. [351690]
7/18/2016123NOTICE OF DEFICIENCY: The party letter Document No. [120] filed by Appellee Accord Healthcare Inc. in 15-2066 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. Please re-file your notice under the correct event "NOTICE REGARDING CONFLICT WITH ARGUMENT DATES." You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [351684]
7/18/2016Notice from Appellee Actavis LLC regarding conflicts with oral argument (August 1-5, September 6-9 or November 7, 2016). Service: 07/18/2016 by email. [351669]
7/18/2016Notice from Appellee Hospira, Inc. regarding conflicts with oral argument (08/05/2016). Service: 07/18/2016 by email. [351658]
7/18/2016120Notice from Appellee Accord Healthcare Inc. regarding conflicts with oral argument (October 3-7, 2016; December 5-9, 2016). Service: 07/18/2016 by email. [351636]
7/18/2016Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (August 1-5, November 7, and December 5, 2016). Service: 07/18/2016 by email. [351632]
7/18/2016Notice from Appellees Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (October 3-7, 2016; December 5-9, 2016). Service: 07/18/2016 by email. [351553]
7/11/20161176 paper copies of the Joint Appendix (Vol. I-III) [115] received from Appellant Millennium Pharmaceuticals, Inc. [350543]
7/11/2016116Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/18/2016. [349767]
7/5/2016JOINT APPENDIX, VOLS. 1- 3 FILED for Millennium Pharmaceuticals, Inc. [113]. Number of Pages: 1,704. Service: 07/05/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/12/2016. [349042]
7/5/2016Statement of Compliance with Fed. Cir. R. 33 for Appellant Millennium Pharmaceuticals, Inc. and Appellees Accord Healthcare Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. Service: 07/05/2016 by email. [348535]
One moment please. Additional information is being loaded. throbber